4//SEC Filing
Mamluk Roni 4
Accession 0000899243-22-000873
CIK 0001797336other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:06 PM ET
Size
5.4 KB
Accession
0000899243-22-000873
Insider Transaction Report
Form 4
Mamluk Roni
DirectorCEO
Transactions
- Award
Stock Option
2022-01-03+127,800→ 127,800 totalExercise: $9.11Exp: 2032-01-02→ Common Stock (127,800 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 3, 2026.
Documents
Issuer
Ayala Pharmaceuticals, Inc.
CIK 0001797336
Entity typeother
Related Parties
1- filerCIK 0001647053
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:06 PM ET
- Size
- 5.4 KB